Tuberous sclerosis complex TSC2 TSC1 mTORC1 ERK Fragile X syndrome mGluR-LTD NMDAR-LTD Tuberous sclerosis complex (TSC) and fragile X syndrome (FXS) are caused by mutations in negative regulators of translation. FXS model mice exhibit enhanced metabotropic glutamate receptor-dependent long-term depression (mGluR-LTD). Therefore, we hypothesized that a mouse model of TSC, ΔRG transgenic mice, also would exhibit enhanced mGluR-LTD. We measured the impact of TSC2-GAP mutations on the mTORC1 and ERK signaling pathways and protein synthesis-dependent hippocampal synaptic plasticity in ΔRG transgenic mice. These mice express a dominant/negative TSC2 that binds to TSC1, but has a deletion and substitution mutation in its GAP-domain, resulting in inactivation of the complex. Consistent with previous studies of several other lines of TSC model mice, we observed elevated S6 phosphorylation in the brains of ΔRG mice, suggesting upregulated translation. Surprisingly, mGluR-LTD was not enhanced, but rather was impaired in the ΔRG transgenic mice, indicating that TSC and FXS have divergent synaptic plasticity phenotypes. Similar to patients with TSC, the ΔRG transgenic mice exhibit elevated ERK signaling. Moreover, the mGluR-LTD impairment displayed by the ΔRG transgenic mice was rescued with the MEK-ERK inhibitor U0126. Our results suggest that the mGluR-LTD impairment observed in ΔRG mice involves aberrant TSC1/2-ERK signaling.
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder that can cause hamartomas, benign and malignant neoplasms, seizures, mental impairment and autism (DiMario, 2004) . At the molecular level, TSC is caused by either the loss or malfunction of either hamartin (TSC1) or tuberin (TSC2), which interact in a heterodimer known as the TSC1/TSC2 complex, to negatively regulate mammalian target of rapamycin complex 1 (mTORC1) (Cheadle et al., 2000) . mTORC1 functions as a molecular gatekeeper for cap-dependent translation initiation in neurons. Activation of the phosphoinositide 3-kinase (PI3K)/Akt and extracellular signal-regulated kinase (ERK) signaling pathways results in the phosphorylation of TSC2 and inhibition of the GTPase-activating protein (GAP) activity of TSC2, which leads to increased levels of Rheb-GTP. This type of signaling activates the mTOR complex 1 (mTORC1) and subsequent phosphorylation ribosomal S6 kinase 1 (S6K1) and eukaryote initiation factor 4E-binding protein (4E-BP), key translation initiation regulators (Cai et al., 2006; Jozwiak, 2006; Jozwiak et al., 2005; Orlova and Crino, 2010; Yang et al., 2006) .
It has been estimated that sporadic cases of TSC range from 60 to 70% of the cases reported, and that TSC1 mutations are significantly underrepresented compared to TSC2 (Jones et al., 1997). TSC2 gene mutations are more frequent and result in a more severe phenotype in TSC patients (i.e. seizures and learning disability), with the exception of reported cases of patients with no mutation identified, as well as one TSC2 mutation that causes a more mild phenotype (Camposano et al., 2009; Dabora et al., 2001; Jansen et al., 2006; Kwiatkowski, 2003) . In addition, the TSC2 gene is more prone than the TSC1 gene to large deletions, rearrangements, and missense mutations. Of particular interest is the finding that missense mutations are clustered within TSC2 exons 34-38, which encode for either Rap1GAP or GAP3 (Maheshwar et al., 1997) . The TSC2-GAP domain is an essential structural domain for the hydrolysis of GTP-bound Rheb to its inactive GDP-bound form (Tee et al., 2003) .
Studies have shown that either loss or malfunction of TSC1 and TSC2 usually results in activation of S6K1 and enhanced ribosomal protein S6 phosphorylation, resulting in defective regulation of cell size and proliferation (Krymskaya, 2003; Uhlmann et al., 2004) .
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